BRINGING INNOVATIVE TREATMENTS TO PATIENTS

Nanocan Therapeutics Corporation


Nanocan Therapeutics Corporation is an early-stage biotechnology company developing novel drug-delivery nanotechnology for more precise and targeted treatment of cancer and respiratory diseases. More precise local treatment can unlock local immune-driven potential and significantly reduce the risk of side effects. Through our partnerships with leading academic research institutions, we are rapidly developing new shorter and efficient combination therapies to help improve the lives of patients and improve global access to care.


Read more about us


THERAPEUTIC AREAS OF FOCUS

With the Company’s novel therapeutics, Nanocan seeks to transform treatments for certain cancers.


Nanocan’s initial products for rollout will target:

  • Prostate Cancer
  • Pancreatic Cancer
  • Cervical Cancer

Nanocan’s next tier of products for rollout will target:

  • Breast Cancer
  • Liver Cancer
  • Lung Cancer
  • Glioblastoma